189 related articles for article (PubMed ID: 7978023)
1. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
[No Abstract] [Full Text] [Related]
2. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
Pham TA; De Freitas R; Sigston E; Vallance N
ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
[TBL] [Abstract][Full Text] [Related]
3. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
4. Early glottic cancer.
DeSanto LW; Olsen KD
Am J Otolaryngol; 1994; 15(4):242-9. PubMed ID: 7978022
[No Abstract] [Full Text] [Related]
5. A critical review of radiotherapy in the management of T1 glottic carcinoma.
Morris MR; Canonico D; Blank C
Am J Otolaryngol; 1994; 15(4):276-80. PubMed ID: 7978026
[TBL] [Abstract][Full Text] [Related]
6. Treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I Cancer From 1988 to 2012.
Khaja SF; Hoffman HT; Pagedar NA
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based review of treatment options for patients with glottic cancer.
Hartl DM; Ferlito A; Brasnu DF; Langendijk JA; Rinaldo A; Silver CE; Wolf GT
Head Neck; 2011 Nov; 33(11):1638-48. PubMed ID: 21990228
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
9. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
[TBL] [Abstract][Full Text] [Related]
10. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
11. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
12. Quality of life, functional outcome, and costs of early glottic cancer.
Smith JC; Johnson JT; Cognetti DM; Landsittel DP; Gooding WE; Cano ER; Myers EN
Laryngoscope; 2003 Jan; 113(1):68-76. PubMed ID: 12514385
[TBL] [Abstract][Full Text] [Related]
13. Recurrence after radiotherapy for glottic carcinoma.
Viani L; Stell PM; Dalby JE
Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
[TBL] [Abstract][Full Text] [Related]
14. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
[TBL] [Abstract][Full Text] [Related]
15. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
16. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
19. Personal experience on horizontal glottectomy. Critical evaluation of long-term results.
Calearo C; Merlo R
ORL J Otorhinolaryngol Relat Spec; 1992; 54(2):100-2. PubMed ID: 1614683
[No Abstract] [Full Text] [Related]
20. Glottic laryngeal carcinoma with fixed vocal cord treated with full-dose radiation, total laryngectomy or combined treatment.
Sandberg N; Mercke C; Turesson I
Acta Oncol; 1990; 29(4):509-11. PubMed ID: 2390276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
